Cerebral Glucose Metabolism Is a Valuable Predictor of Survival in Patients with Lewy Body Diseases

Joachim Brumberg,Ganna Blazhenets,Sabrina Bühler,Johannes Fostitsch,Michel Rijntjes,Yilong Ma,David Eidelberg,Cornelius Weiller,Wolfgang H. Jost,Lars Frings,Nils Schröter,Philipp T. Meyer
DOI: https://doi.org/10.1002/ana.27005
IF: 11.2
2024-06-20
Annals of Neurology
Abstract:Objective Patients with Lewy body diseases have an increased risk of dementia, which is a significant predictor for survival. Posterior cortical hypometabolism on [18F]fluorodeoxyglucose positron emission tomography (PET) precedes the development of dementia by years. We therefore examined the prognostic value of cerebral glucose metabolism for survival. Methods We enrolled patients diagnosed with Parkinson's disease (PD), Parkinson's disease with dementia, or dementia with Lewy bodies who underwent [18F]fluorodeoxyglucose PET. Regional cerebral metabolism of each patient was analyzed by determining the expression of the PD‐related cognitive pattern (Z‐score) and by visual PET rating. We analyzed the predictive value of PET for overall survival using Cox regression analyses (age‐ and sex‐corrected) and calculated prognostic indices for the best model. Results Glucose metabolism was a significant predictor of survival in 259 included patients (n = 118 events; hazard ratio: 1.4 [1.2–1.6] per Z‐score; hazard ratio: 1.8 [1.5–2.2] per visual PET rating score; both p
neurosciences,clinical neurology
What problem does this paper attempt to address?